Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear.
Coronavirus and COVID-19 updates
Data and infographic updates on the COVID-19 pandemic.
Scientists urge caution over hints of success emerging from small human and animal studies.
Google, Apple and researchers partner to build more secure and effective tools, but poor adoption could blunt efficacy.
US scientists say that better data, testing and hospital preparedness are key to erasing inequalities — and to defeating the pandemic overall.
Stopping the pandemic could rely on breakneck efforts to visualize SARS-CoV-2 proteins and use them to design drugs and vaccines.
Drug manufacturers face supply-chain weaknesses and sourcing issues as they ramp up complex production processes to meet global demand.
Scientists are piecing together how SARS-CoV-2 operates, where it came from and what it might do next — but pressing questions remain about the source of COVID-19.
Eight ways in which scientists hope to provide immunity to SARS-CoV-2 .
Researchers sift through data to compare nations’ vastly different containment measures.
Toxic living conditions have long inflated death rates. Scientists must learn to track these patterns of inequality.
Computational models, cell studies and animal experiments are being used to pinpoint the viral host that kicked off the pandemic.
Breakneck triage nails many diagnoses, but deeper treatment is needed.
With questionable coronavirus content flooding airwaves and online channels, what’s being done to limit its impact?
But there’s no evidence that dogs can pass the virus to people.
Studies of social networks show that opposition to vaccines is small but far-reaching — and growing.
The pandemic has given rise to too many small and uncontrolled clinical trials.
Research begins to pick apart the mechanisms behind a deadly COVID-19 complication.
The kit has been granted approval under ‘emergency use’ provisions, and should help to ease testing backlogs in the country.
Outbreaks among those unable to isolate are spreading under the radar. We hear about the researchers scrambling to get a handle on the situation.
Schools are beginning to reopen — but scientists are still trying to understand what the deal is with kids and COVID-19.
Strained health-care systems, lockdowns and safety requirements have hampered efforts to collect tissue from patients that is crucial to research.
Close living quarters and a lack of testing among homeless people across the United States threaten the nation’s ability to control the pandemic, researchers say.
Repositories are rapidly disseminating crucial pandemic science — and they’re screening more closely to guard against poor-quality work.
Scientists say rigorous trial data are needed to show that remedies are safe and effective.
Countries are starting to lift restrictions on movement, but there is little consensus on how this should be done. Sharing best practice is the way forward.
A diagnosis is rarely a solution to problems caused by poverty and inequality.
Arthur Turrell tells Nature how Bank of England researchers are fusing economics and epidemiology to study the complex effects of the pandemic.
Developers and funders are laying the groundwork for efficacy trials, but only a handful of vaccines are likely to make the cut.
Despite conflicting studies, results from largest trial yet show the antiviral speeds up recovery, putting it on track to become a standard of care in the United States.
Governments see coronavirus apps as key to releasing lockdowns. In exchange for people’s health data, they must promise to work together to develop the highest standards of safety and efficacy.
While the world focuses on the pandemic, the United States is adopting controversial policies at the Environmental Protection Agency.
The scientific community must take up cudgels in the battle against bunk.
With politicians touting the potential benefits of malaria drugs to fight COVID-19, some people are turning away from clinical trials of other therapies.
From Bangladesh to Somalia, researchers and aid workers are taking different steps to protect people among the most vulnerable to the pandemic.
The role of antibody tests in controlling the pandemic, how public-health spending could curtail an economic crisis, and the efforts of the open hardware community.
Countries must join forces to avert a global food crisis from COVID-19.
Nature recorded major events as the pandemic spread across the globe.
Despite uncertainties, some scientists are betting that blood tests will help end lockdowns and get people back to work.
‘Closing borders is ridiculous’: the epidemiologist behind Sweden’s controversial coronavirus strategy
Anders Tegnell talks to Nature about the nation’s ‘trust-based’ approach to tackling the pandemic.
An online survey reveals bottlenecks and challenges and barriers faced by more than 1,700 biology labs.
Touted as society’s way out of widespread lockdowns, scientists say the true potential of these rapidly developed tests is still unknown.
Researchers everywhere must continue to press their lawmakers to act now and challenge US President Donald Trump’s undermining of the global health agency.
I’m curious what lockdown will reveal about the ‘maternal wall’ that can block faculty advancement.
The Coronapod team pick through the latest news, plus we hear from the researchers making lemonade out of lockdown lemons.
Trump withholds funding from the WHO, how COVID-19 kills, and controlling misinformation while communicating risk.
Some scientists welcome government vetting because it could stop poor-quality COVID-19 papers being published – others fear it is an attempt to control information.
The pandemic lays bare the failure to quarantine online scams, hoaxes and lies amid political battles.
Researchers warn production constraints and hoarding could limit SARS-CoV-2 vaccine supplies.
Doctors are reaching for drugs that dampen the immune response — but these also undermine the body’s own fight against the coronavirus.
COVID-19’s lethality provides a grim opportunity to track its spread.
US labs that underwent huge efforts to retool for COVID-19 testing still aren’t operating at full capacity. Experts say the lack of a national strategy is largely to blame.
The pandemic is fuelling deplorable racism and discrimination, especially against Asian people. Education and research will also pay the price.
The latest on the British response, and what have low- and middle-income countries done to prepare for the pandemic?
And a new, influential research consortium launches a bid to accelerate trials in low-income countries.
Wastewater testing could also be used as an early-warning sign if the virus returns.
The World Health Organization says the evidence is not compelling, but scientists warn that gathering sufficient data could take years and cost lives.
How epidemiologists rushed to model the coronavirus pandemic.
Snapshots from four nations struggling to limit deaths faster than the United States and other wealthy countries.
Scientists are teaming up to fight COVID-19. Presidents and prime ministers should, too.
But scientists say it’s unclear whether felines can spread the virus to people, so pet owners need not panic yet.
A reduction in seismic noise because of changes in human activity is a boon for geoscientists.
Other countries on lockdown will be watching for a resurgence of infections in Hubei province now that travel restrictions are lifting.
As universities scale back operations and scientists observe stay-at-home orders, many are struggling to protect their research and the animals that power it.
Governments need to think twice before they suppress messages related to COVID-19.
As labs shut down around the world, researchers are finding creative ways to donate their time, supplies and expertise.
Could blood plasma from coronavirus survivors be an effective short-term treatment for patients?
Radical proposal to conduct ‘human challenge’ studies could dramatically speed up vaccine research.
Close confines help the virus to spread, but closed environments are also an ideal place to study how the new coronavirus behaves.
Studies grind to a halt as fears of health-care shortages and risk of exposure put the brakes on clinical research.
New York City researchers hope antibody-rich plasma can keep people out of intensive care.
Share data, boost incentives and reduce red tape to identify drugs for use in emerging coronavirus epidemics.
Research will offer the best exit strategy, and we will do everything we can to help researchers and clinicians realize that goal.
Nature examines how viral diagnostic tests work, why testing has varied around the world and the CRISPR-based tests under development to fight COVID-19.
If testing and contact tracing are key to controlling the coronavirus outbreak, why aren’t they being done around the world?
Doing science during the quarantine in northern Italy has shown me that creativity needs connection. By Alberto Bardelli
Some experts warn that accelerated testing will involve some risky trade-offs.
From papers published to carbon emissions to confirmed cases, these data reveal an unprecedented viral outbreak and its impacts around the world.
Researchers are studying the effects of China’s lockdowns to glean insights about controlling the viral pandemic.
Follow World Health Organization advice, end secrecy in decision-making and cooperate globally.
Nick Howe investigates how researchers around the world are answering the call for science.
As scientific meetings are cancelled worldwide, researchers are rethinking how they network — a move that some say is long overdue.
Three leading health officials talk about gauging the size of local outbreaks, and why containment strategies aren’t futile yet.
Mice originally bred for SARS research are in high demand.
Researchers have identified microscopic features that could make the pathogen more infectious than the SARS virus — and serve as drug targets.
As cases in Washington state soar, virologists are working around the clock to diagnose cases, reveal routes of transmission and test treatments.
Pangolins are a prime suspect, but a slew of genetic analyses has yet to find conclusive proof.
As outbreaks surge worldwide, scientists fear that COVID-19 might soon become pandemic.
From laboratory closures to equipment shortages, researchers worldwide tell Nature how they have been affected by the epidemic.
Officials want to know but predictions vary wildly, from now to after hundreds of millions of people are infected.
Concerns are rising about the virus’s potential to circulate undetected in Africa and Asia.
World leaders and international donors must strengthen the most vulnerable nations’ health-care systems.
Reporter Heidi Ledford explains three key fields of research
Genetic sequences of viruses isolated from the scaly animals are 99% similar to that of the circulating virus — but the work is yet to be formally published.
As the new coronavirus continues its deadly spread, researchers must ensure that their work on this outbreak is shared rapidly and openly.
Scientists need the pathogen to probe the biology of the emerging infection and to develop tests, drugs and vaccines.
Experts weigh up the best- and worst-case scenarios as the World Health Organization declares a global health emergency.
Research papers and preprints are appearing every day as researchers worldwide respond to the outbreak.
How science can help control the outbreak
Measures to contain a new virus’s spread have cut off the city's researchers.
One genetic analysis suggests reptilian reservoir — but researchers doubt that the coronavirus could have originated in animals other than birds or mammals.
Researchers are racing to find out more about the epidemiology and genetic sequence of the coronavirus spreading in Asia and beyond.
Chinese officials have confirmed that the virus is spreading between people, but it’s still unclear how easily this happens.
Chinese officials reported more than 100 new infections and South Korea confirmed its first case.
The legacy of SARS has haunted the race to understand a respiratory infection that has affected 60 people.